Ten-year results of hypofractionated whole breast radiotherapy and intraoperative electron boost in premenopausal women
• Boost dose is beneficial for young patients affected by breast cancer. • Intraoperative electrons (IOERT) boost and hypofractionated whole breast irradiation (HWBI) represent a suitable modality. • Local control with IOERT/HWBI was excellent, even in very young patients. • High tumor bed fibrosis...
Ausführliche Beschreibung
Autor*in: |
Leonardi, Maria Cristina [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2022 |
---|
Schlagwörter: |
---|
Umfang: |
10 |
---|
Übergeordnetes Werk: |
Enthalten in: Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells - Han, Xiaobing ELSEVIER, 2021, journal of the European Society for Therapeutic Radiology and Oncology, Amsterdam [u.a.] |
---|---|
Übergeordnetes Werk: |
volume:177 ; year:2022 ; pages:71-80 ; extent:10 |
Links: |
---|
DOI / URN: |
10.1016/j.radonc.2022.10.025 |
---|
Katalog-ID: |
ELV059880856 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV059880856 | ||
003 | DE-627 | ||
005 | 20230625014849.0 | ||
007 | cr uuu---uuuuu | ||
008 | 221219s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.radonc.2022.10.025 |2 doi | |
028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001997.pica |
035 | |a (DE-627)ELV059880856 | ||
035 | |a (ELSEVIER)S0167-8140(22)04519-4 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 570 |a 540 |q VZ |
100 | 1 | |a Leonardi, Maria Cristina |e verfasserin |4 aut | |
245 | 1 | 0 | |a Ten-year results of hypofractionated whole breast radiotherapy and intraoperative electron boost in premenopausal women |
264 | 1 | |c 2022 | |
300 | |a 10 | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a • Boost dose is beneficial for young patients affected by breast cancer. • Intraoperative electrons (IOERT) boost and hypofractionated whole breast irradiation (HWBI) represent a suitable modality. • Local control with IOERT/HWBI was excellent, even in very young patients. • High tumor bed fibrosis was observed due to high cumulative EQD2 boost dose. | ||
650 | 7 | |a Intraoperative electron radiotherapy |2 Elsevier | |
650 | 7 | |a Boost |2 Elsevier | |
650 | 7 | |a Outcome |2 Elsevier | |
650 | 7 | |a Breast cancer |2 Elsevier | |
700 | 1 | |a Cormio, Chiara Fausta |4 oth | |
700 | 1 | |a Frassoni, Samuele |4 oth | |
700 | 1 | |a Dicuonzo, Samantha |4 oth | |
700 | 1 | |a Fodor, Cristiana |4 oth | |
700 | 1 | |a Intra, Mattia |4 oth | |
700 | 1 | |a Zerella, Maria Alessia |4 oth | |
700 | 1 | |a Morra, Anna |4 oth | |
700 | 1 | |a Cattani, Federica |4 oth | |
700 | 1 | |a Comi, Stefania |4 oth | |
700 | 1 | |a Fusco, Nicola |4 oth | |
700 | 1 | |a Zaffaroni, Mattia |4 oth | |
700 | 1 | |a Galimberti, Viviana |4 oth | |
700 | 1 | |a Veronesi, Paolo |4 oth | |
700 | 1 | |a Dellapasqua, Silvia |4 oth | |
700 | 1 | |a De Lorenzi, Francesca |4 oth | |
700 | 1 | |a Ivaldi, Giovanni Battista |4 oth | |
700 | 1 | |a Bagnardi, Vincenzo |4 oth | |
700 | 1 | |a Orecchia, Roberto |4 oth | |
700 | 1 | |a Rojas, Damaris Patricia |4 oth | |
700 | 1 | |a Jereczek-Fossa, Barbara Alicja |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Han, Xiaobing ELSEVIER |t Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells |d 2021 |d journal of the European Society for Therapeutic Radiology and Oncology |g Amsterdam [u.a.] |w (DE-627)ELV00004122X |
773 | 1 | 8 | |g volume:177 |g year:2022 |g pages:71-80 |g extent:10 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.radonc.2022.10.025 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
912 | |a SSG-OLC-PHA | ||
951 | |a AR | ||
952 | |d 177 |j 2022 |h 71-80 |g 10 |
author_variant |
m c l mc mcl |
---|---|
matchkey_str |
leonardimariacristinacormiochiarafaustaf:2022----:eyarslsfyorcintdhlbesrdohrpadnroeaielcr |
hierarchy_sort_str |
2022 |
publishDate |
2022 |
allfields |
10.1016/j.radonc.2022.10.025 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001997.pica (DE-627)ELV059880856 (ELSEVIER)S0167-8140(22)04519-4 DE-627 ger DE-627 rakwb eng 570 540 VZ Leonardi, Maria Cristina verfasserin aut Ten-year results of hypofractionated whole breast radiotherapy and intraoperative electron boost in premenopausal women 2022 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Boost dose is beneficial for young patients affected by breast cancer. • Intraoperative electrons (IOERT) boost and hypofractionated whole breast irradiation (HWBI) represent a suitable modality. • Local control with IOERT/HWBI was excellent, even in very young patients. • High tumor bed fibrosis was observed due to high cumulative EQD2 boost dose. Intraoperative electron radiotherapy Elsevier Boost Elsevier Outcome Elsevier Breast cancer Elsevier Cormio, Chiara Fausta oth Frassoni, Samuele oth Dicuonzo, Samantha oth Fodor, Cristiana oth Intra, Mattia oth Zerella, Maria Alessia oth Morra, Anna oth Cattani, Federica oth Comi, Stefania oth Fusco, Nicola oth Zaffaroni, Mattia oth Galimberti, Viviana oth Veronesi, Paolo oth Dellapasqua, Silvia oth De Lorenzi, Francesca oth Ivaldi, Giovanni Battista oth Bagnardi, Vincenzo oth Orecchia, Roberto oth Rojas, Damaris Patricia oth Jereczek-Fossa, Barbara Alicja oth Enthalten in Elsevier Science Han, Xiaobing ELSEVIER Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells 2021 journal of the European Society for Therapeutic Radiology and Oncology Amsterdam [u.a.] (DE-627)ELV00004122X volume:177 year:2022 pages:71-80 extent:10 https://doi.org/10.1016/j.radonc.2022.10.025 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 177 2022 71-80 10 |
spelling |
10.1016/j.radonc.2022.10.025 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001997.pica (DE-627)ELV059880856 (ELSEVIER)S0167-8140(22)04519-4 DE-627 ger DE-627 rakwb eng 570 540 VZ Leonardi, Maria Cristina verfasserin aut Ten-year results of hypofractionated whole breast radiotherapy and intraoperative electron boost in premenopausal women 2022 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Boost dose is beneficial for young patients affected by breast cancer. • Intraoperative electrons (IOERT) boost and hypofractionated whole breast irradiation (HWBI) represent a suitable modality. • Local control with IOERT/HWBI was excellent, even in very young patients. • High tumor bed fibrosis was observed due to high cumulative EQD2 boost dose. Intraoperative electron radiotherapy Elsevier Boost Elsevier Outcome Elsevier Breast cancer Elsevier Cormio, Chiara Fausta oth Frassoni, Samuele oth Dicuonzo, Samantha oth Fodor, Cristiana oth Intra, Mattia oth Zerella, Maria Alessia oth Morra, Anna oth Cattani, Federica oth Comi, Stefania oth Fusco, Nicola oth Zaffaroni, Mattia oth Galimberti, Viviana oth Veronesi, Paolo oth Dellapasqua, Silvia oth De Lorenzi, Francesca oth Ivaldi, Giovanni Battista oth Bagnardi, Vincenzo oth Orecchia, Roberto oth Rojas, Damaris Patricia oth Jereczek-Fossa, Barbara Alicja oth Enthalten in Elsevier Science Han, Xiaobing ELSEVIER Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells 2021 journal of the European Society for Therapeutic Radiology and Oncology Amsterdam [u.a.] (DE-627)ELV00004122X volume:177 year:2022 pages:71-80 extent:10 https://doi.org/10.1016/j.radonc.2022.10.025 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 177 2022 71-80 10 |
allfields_unstemmed |
10.1016/j.radonc.2022.10.025 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001997.pica (DE-627)ELV059880856 (ELSEVIER)S0167-8140(22)04519-4 DE-627 ger DE-627 rakwb eng 570 540 VZ Leonardi, Maria Cristina verfasserin aut Ten-year results of hypofractionated whole breast radiotherapy and intraoperative electron boost in premenopausal women 2022 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Boost dose is beneficial for young patients affected by breast cancer. • Intraoperative electrons (IOERT) boost and hypofractionated whole breast irradiation (HWBI) represent a suitable modality. • Local control with IOERT/HWBI was excellent, even in very young patients. • High tumor bed fibrosis was observed due to high cumulative EQD2 boost dose. Intraoperative electron radiotherapy Elsevier Boost Elsevier Outcome Elsevier Breast cancer Elsevier Cormio, Chiara Fausta oth Frassoni, Samuele oth Dicuonzo, Samantha oth Fodor, Cristiana oth Intra, Mattia oth Zerella, Maria Alessia oth Morra, Anna oth Cattani, Federica oth Comi, Stefania oth Fusco, Nicola oth Zaffaroni, Mattia oth Galimberti, Viviana oth Veronesi, Paolo oth Dellapasqua, Silvia oth De Lorenzi, Francesca oth Ivaldi, Giovanni Battista oth Bagnardi, Vincenzo oth Orecchia, Roberto oth Rojas, Damaris Patricia oth Jereczek-Fossa, Barbara Alicja oth Enthalten in Elsevier Science Han, Xiaobing ELSEVIER Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells 2021 journal of the European Society for Therapeutic Radiology and Oncology Amsterdam [u.a.] (DE-627)ELV00004122X volume:177 year:2022 pages:71-80 extent:10 https://doi.org/10.1016/j.radonc.2022.10.025 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 177 2022 71-80 10 |
allfieldsGer |
10.1016/j.radonc.2022.10.025 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001997.pica (DE-627)ELV059880856 (ELSEVIER)S0167-8140(22)04519-4 DE-627 ger DE-627 rakwb eng 570 540 VZ Leonardi, Maria Cristina verfasserin aut Ten-year results of hypofractionated whole breast radiotherapy and intraoperative electron boost in premenopausal women 2022 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Boost dose is beneficial for young patients affected by breast cancer. • Intraoperative electrons (IOERT) boost and hypofractionated whole breast irradiation (HWBI) represent a suitable modality. • Local control with IOERT/HWBI was excellent, even in very young patients. • High tumor bed fibrosis was observed due to high cumulative EQD2 boost dose. Intraoperative electron radiotherapy Elsevier Boost Elsevier Outcome Elsevier Breast cancer Elsevier Cormio, Chiara Fausta oth Frassoni, Samuele oth Dicuonzo, Samantha oth Fodor, Cristiana oth Intra, Mattia oth Zerella, Maria Alessia oth Morra, Anna oth Cattani, Federica oth Comi, Stefania oth Fusco, Nicola oth Zaffaroni, Mattia oth Galimberti, Viviana oth Veronesi, Paolo oth Dellapasqua, Silvia oth De Lorenzi, Francesca oth Ivaldi, Giovanni Battista oth Bagnardi, Vincenzo oth Orecchia, Roberto oth Rojas, Damaris Patricia oth Jereczek-Fossa, Barbara Alicja oth Enthalten in Elsevier Science Han, Xiaobing ELSEVIER Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells 2021 journal of the European Society for Therapeutic Radiology and Oncology Amsterdam [u.a.] (DE-627)ELV00004122X volume:177 year:2022 pages:71-80 extent:10 https://doi.org/10.1016/j.radonc.2022.10.025 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 177 2022 71-80 10 |
allfieldsSound |
10.1016/j.radonc.2022.10.025 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001997.pica (DE-627)ELV059880856 (ELSEVIER)S0167-8140(22)04519-4 DE-627 ger DE-627 rakwb eng 570 540 VZ Leonardi, Maria Cristina verfasserin aut Ten-year results of hypofractionated whole breast radiotherapy and intraoperative electron boost in premenopausal women 2022 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Boost dose is beneficial for young patients affected by breast cancer. • Intraoperative electrons (IOERT) boost and hypofractionated whole breast irradiation (HWBI) represent a suitable modality. • Local control with IOERT/HWBI was excellent, even in very young patients. • High tumor bed fibrosis was observed due to high cumulative EQD2 boost dose. Intraoperative electron radiotherapy Elsevier Boost Elsevier Outcome Elsevier Breast cancer Elsevier Cormio, Chiara Fausta oth Frassoni, Samuele oth Dicuonzo, Samantha oth Fodor, Cristiana oth Intra, Mattia oth Zerella, Maria Alessia oth Morra, Anna oth Cattani, Federica oth Comi, Stefania oth Fusco, Nicola oth Zaffaroni, Mattia oth Galimberti, Viviana oth Veronesi, Paolo oth Dellapasqua, Silvia oth De Lorenzi, Francesca oth Ivaldi, Giovanni Battista oth Bagnardi, Vincenzo oth Orecchia, Roberto oth Rojas, Damaris Patricia oth Jereczek-Fossa, Barbara Alicja oth Enthalten in Elsevier Science Han, Xiaobing ELSEVIER Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells 2021 journal of the European Society for Therapeutic Radiology and Oncology Amsterdam [u.a.] (DE-627)ELV00004122X volume:177 year:2022 pages:71-80 extent:10 https://doi.org/10.1016/j.radonc.2022.10.025 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 177 2022 71-80 10 |
language |
English |
source |
Enthalten in Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells Amsterdam [u.a.] volume:177 year:2022 pages:71-80 extent:10 |
sourceStr |
Enthalten in Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells Amsterdam [u.a.] volume:177 year:2022 pages:71-80 extent:10 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
Intraoperative electron radiotherapy Boost Outcome Breast cancer |
dewey-raw |
570 |
isfreeaccess_bool |
false |
container_title |
Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells |
authorswithroles_txt_mv |
Leonardi, Maria Cristina @@aut@@ Cormio, Chiara Fausta @@oth@@ Frassoni, Samuele @@oth@@ Dicuonzo, Samantha @@oth@@ Fodor, Cristiana @@oth@@ Intra, Mattia @@oth@@ Zerella, Maria Alessia @@oth@@ Morra, Anna @@oth@@ Cattani, Federica @@oth@@ Comi, Stefania @@oth@@ Fusco, Nicola @@oth@@ Zaffaroni, Mattia @@oth@@ Galimberti, Viviana @@oth@@ Veronesi, Paolo @@oth@@ Dellapasqua, Silvia @@oth@@ De Lorenzi, Francesca @@oth@@ Ivaldi, Giovanni Battista @@oth@@ Bagnardi, Vincenzo @@oth@@ Orecchia, Roberto @@oth@@ Rojas, Damaris Patricia @@oth@@ Jereczek-Fossa, Barbara Alicja @@oth@@ |
publishDateDaySort_date |
2022-01-01T00:00:00Z |
hierarchy_top_id |
ELV00004122X |
dewey-sort |
3570 |
id |
ELV059880856 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV059880856</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625014849.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">221219s2022 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.radonc.2022.10.025</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001997.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV059880856</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0167-8140(22)04519-4</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Leonardi, Maria Cristina</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Ten-year results of hypofractionated whole breast radiotherapy and intraoperative electron boost in premenopausal women</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">10</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Boost dose is beneficial for young patients affected by breast cancer. • Intraoperative electrons (IOERT) boost and hypofractionated whole breast irradiation (HWBI) represent a suitable modality. • Local control with IOERT/HWBI was excellent, even in very young patients. • High tumor bed fibrosis was observed due to high cumulative EQD2 boost dose.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Intraoperative electron radiotherapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Boost</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Outcome</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Breast cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cormio, Chiara Fausta</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Frassoni, Samuele</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dicuonzo, Samantha</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fodor, Cristiana</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Intra, Mattia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zerella, Maria Alessia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Morra, Anna</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cattani, Federica</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Comi, Stefania</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fusco, Nicola</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zaffaroni, Mattia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Galimberti, Viviana</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Veronesi, Paolo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dellapasqua, Silvia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">De Lorenzi, Francesca</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ivaldi, Giovanni Battista</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bagnardi, Vincenzo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Orecchia, Roberto</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rojas, Damaris Patricia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jereczek-Fossa, Barbara Alicja</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Han, Xiaobing ELSEVIER</subfield><subfield code="t">Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells</subfield><subfield code="d">2021</subfield><subfield code="d">journal of the European Society for Therapeutic Radiology and Oncology</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV00004122X</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:177</subfield><subfield code="g">year:2022</subfield><subfield code="g">pages:71-80</subfield><subfield code="g">extent:10</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.radonc.2022.10.025</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">177</subfield><subfield code="j">2022</subfield><subfield code="h">71-80</subfield><subfield code="g">10</subfield></datafield></record></collection>
|
author |
Leonardi, Maria Cristina |
spellingShingle |
Leonardi, Maria Cristina ddc 570 Elsevier Intraoperative electron radiotherapy Elsevier Boost Elsevier Outcome Elsevier Breast cancer Ten-year results of hypofractionated whole breast radiotherapy and intraoperative electron boost in premenopausal women |
authorStr |
Leonardi, Maria Cristina |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV00004122X |
format |
electronic Article |
dewey-ones |
570 - Life sciences; biology 540 - Chemistry & allied sciences |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
570 540 VZ Ten-year results of hypofractionated whole breast radiotherapy and intraoperative electron boost in premenopausal women Intraoperative electron radiotherapy Elsevier Boost Elsevier Outcome Elsevier Breast cancer Elsevier |
topic |
ddc 570 Elsevier Intraoperative electron radiotherapy Elsevier Boost Elsevier Outcome Elsevier Breast cancer |
topic_unstemmed |
ddc 570 Elsevier Intraoperative electron radiotherapy Elsevier Boost Elsevier Outcome Elsevier Breast cancer |
topic_browse |
ddc 570 Elsevier Intraoperative electron radiotherapy Elsevier Boost Elsevier Outcome Elsevier Breast cancer |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
c f c cf cfc s f sf s d sd c f cf m i mi m a z ma maz a m am f c fc s c sc n f nf m z mz v g vg p v pv s d sd l f d lf lfd g b i gb gbi v b vb r o ro d p r dp dpr b a j f baj bajf |
hierarchy_parent_title |
Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells |
hierarchy_parent_id |
ELV00004122X |
dewey-tens |
570 - Life sciences; biology 540 - Chemistry |
hierarchy_top_title |
Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV00004122X |
title |
Ten-year results of hypofractionated whole breast radiotherapy and intraoperative electron boost in premenopausal women |
ctrlnum |
(DE-627)ELV059880856 (ELSEVIER)S0167-8140(22)04519-4 |
title_full |
Ten-year results of hypofractionated whole breast radiotherapy and intraoperative electron boost in premenopausal women |
author_sort |
Leonardi, Maria Cristina |
journal |
Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells |
journalStr |
Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
500 - Science |
recordtype |
marc |
publishDateSort |
2022 |
contenttype_str_mv |
zzz |
container_start_page |
71 |
author_browse |
Leonardi, Maria Cristina |
container_volume |
177 |
physical |
10 |
class |
570 540 VZ |
format_se |
Elektronische Aufsätze |
author-letter |
Leonardi, Maria Cristina |
doi_str_mv |
10.1016/j.radonc.2022.10.025 |
dewey-full |
570 540 |
title_sort |
ten-year results of hypofractionated whole breast radiotherapy and intraoperative electron boost in premenopausal women |
title_auth |
Ten-year results of hypofractionated whole breast radiotherapy and intraoperative electron boost in premenopausal women |
abstract |
• Boost dose is beneficial for young patients affected by breast cancer. • Intraoperative electrons (IOERT) boost and hypofractionated whole breast irradiation (HWBI) represent a suitable modality. • Local control with IOERT/HWBI was excellent, even in very young patients. • High tumor bed fibrosis was observed due to high cumulative EQD2 boost dose. |
abstractGer |
• Boost dose is beneficial for young patients affected by breast cancer. • Intraoperative electrons (IOERT) boost and hypofractionated whole breast irradiation (HWBI) represent a suitable modality. • Local control with IOERT/HWBI was excellent, even in very young patients. • High tumor bed fibrosis was observed due to high cumulative EQD2 boost dose. |
abstract_unstemmed |
• Boost dose is beneficial for young patients affected by breast cancer. • Intraoperative electrons (IOERT) boost and hypofractionated whole breast irradiation (HWBI) represent a suitable modality. • Local control with IOERT/HWBI was excellent, even in very young patients. • High tumor bed fibrosis was observed due to high cumulative EQD2 boost dose. |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
title_short |
Ten-year results of hypofractionated whole breast radiotherapy and intraoperative electron boost in premenopausal women |
url |
https://doi.org/10.1016/j.radonc.2022.10.025 |
remote_bool |
true |
author2 |
Cormio, Chiara Fausta Frassoni, Samuele Dicuonzo, Samantha Fodor, Cristiana Intra, Mattia Zerella, Maria Alessia Morra, Anna Cattani, Federica Comi, Stefania Fusco, Nicola Zaffaroni, Mattia Galimberti, Viviana Veronesi, Paolo Dellapasqua, Silvia De Lorenzi, Francesca Ivaldi, Giovanni Battista Bagnardi, Vincenzo Orecchia, Roberto Rojas, Damaris Patricia Jereczek-Fossa, Barbara Alicja |
author2Str |
Cormio, Chiara Fausta Frassoni, Samuele Dicuonzo, Samantha Fodor, Cristiana Intra, Mattia Zerella, Maria Alessia Morra, Anna Cattani, Federica Comi, Stefania Fusco, Nicola Zaffaroni, Mattia Galimberti, Viviana Veronesi, Paolo Dellapasqua, Silvia De Lorenzi, Francesca Ivaldi, Giovanni Battista Bagnardi, Vincenzo Orecchia, Roberto Rojas, Damaris Patricia Jereczek-Fossa, Barbara Alicja |
ppnlink |
ELV00004122X |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth |
doi_str |
10.1016/j.radonc.2022.10.025 |
up_date |
2024-07-06T23:18:51.634Z |
_version_ |
1803873609723150336 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV059880856</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625014849.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">221219s2022 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.radonc.2022.10.025</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001997.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV059880856</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0167-8140(22)04519-4</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Leonardi, Maria Cristina</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Ten-year results of hypofractionated whole breast radiotherapy and intraoperative electron boost in premenopausal women</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">10</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Boost dose is beneficial for young patients affected by breast cancer. • Intraoperative electrons (IOERT) boost and hypofractionated whole breast irradiation (HWBI) represent a suitable modality. • Local control with IOERT/HWBI was excellent, even in very young patients. • High tumor bed fibrosis was observed due to high cumulative EQD2 boost dose.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Intraoperative electron radiotherapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Boost</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Outcome</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Breast cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cormio, Chiara Fausta</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Frassoni, Samuele</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dicuonzo, Samantha</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fodor, Cristiana</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Intra, Mattia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zerella, Maria Alessia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Morra, Anna</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cattani, Federica</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Comi, Stefania</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fusco, Nicola</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zaffaroni, Mattia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Galimberti, Viviana</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Veronesi, Paolo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dellapasqua, Silvia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">De Lorenzi, Francesca</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ivaldi, Giovanni Battista</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bagnardi, Vincenzo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Orecchia, Roberto</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rojas, Damaris Patricia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jereczek-Fossa, Barbara Alicja</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Han, Xiaobing ELSEVIER</subfield><subfield code="t">Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells</subfield><subfield code="d">2021</subfield><subfield code="d">journal of the European Society for Therapeutic Radiology and Oncology</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV00004122X</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:177</subfield><subfield code="g">year:2022</subfield><subfield code="g">pages:71-80</subfield><subfield code="g">extent:10</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.radonc.2022.10.025</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">177</subfield><subfield code="j">2022</subfield><subfield code="h">71-80</subfield><subfield code="g">10</subfield></datafield></record></collection>
|
score |
7.4007883 |